Literature DB >> 10762272

A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.

G Fimland1, L Johnsen, L Axelsson, M B Brurberg, I F Nes, V G Eijsink, J Nissen-Meyer.   

Abstract

Several lactic acid bacteria produce so-called pediocin-like bacteriocins that share sequence characteristics, but differ in activity and target cell specificity. The significance of a C-terminal disulfide bridge present in only a few of these bacteriocins was studied by site-directed mutagenesis of pediocin PA-1 (which naturally contains the bridge) and sakacin P (which lacks the bridge). Introduction of the C-terminal bridge into sakacin P broadened the target cell specificity of this bacteriocin, as illustrated by the fact that the mutants were 10 to 20 times more potent than the wild-type toward certain indicator strains, whereas the potency toward other indicator strains remained essentially unchanged. Like pediocin PA-1, disulfide-containing sakacin P mutants had the same potency at 20 and 37 degrees C, whereas wild-type sakacin P was approximately 10 times less potent at 37 degrees C than at 20 degrees C. Reciprocal effects on target cell specificity and the temperature dependence of potency were observed upon studying the effect of removing the C-terminal disulfide bridge from pediocin PA-1 by Cys-->Ser mutations. These results clearly show that a C-terminal disulfide bridge in pediocin-like bacteriocins contributes to widening of the antimicrobial spectrum as well as to higher potency at elevated temperatures. Interestingly, the differences between sakacin P and pediocin PA-1 in terms of the temperature dependency of their activities correlated well with the optimal temperatures for bacteriocin production and growth of the bacteriocin-producing strain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762272      PMCID: PMC111334          DOI: 10.1128/JB.182.9.2643-2648.2000

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  34 in total

1.  Purification and amino acid sequence of sakacin A, a bacteriocin from Lactobacillus sake Lb706.

Authors:  A Holck; L Axelsson; S E Birkeland; T Aukrust; H Blom
Journal:  J Gen Microbiol       Date:  1992-12

2.  Purification and primary structure of pediocin PA-1 produced by Pediococcus acidilactici PAC-1.0.

Authors:  J T Henderson; A L Chopko; P D van Wassenaar
Journal:  Arch Biochem Biophys       Date:  1992-05-15       Impact factor: 4.013

3.  Influence of Growth Conditions on the Production of a Bacteriocin, Pediocin AcH, by Pediococcus acidilactici H.

Authors:  S R Biswas; P Ray; M C Johnson; B Ray
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

4.  Characterization of leucocin A-UAL 187 and cloning of the bacteriocin gene from Leuconostoc gelidum.

Authors:  J W Hastings; M Sailer; K Johnson; K L Roy; J C Vederas; M E Stiles
Journal:  J Bacteriol       Date:  1991-12       Impact factor: 3.490

5.  Transformation of Lactobacillus by electroporation.

Authors:  T W Aukrust; M B Brurberg; I F Nes
Journal:  Methods Mol Biol       Date:  1995

6.  Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria.

Authors:  Y Wang; M E Henz; N L Gallagher; S Chai; A C Gibbs; L Z Yan; M E Stiles; D S Wishart; J C Vederas
Journal:  Biochemistry       Date:  1999-11-23       Impact factor: 3.162

7.  Purification and amino acid sequence of a bacteriocin produced by Pediococcus acidilactici.

Authors:  J C Nieto Lozano; J N Meyer; K Sletten; C Peláz; I F Nes
Journal:  J Gen Microbiol       Date:  1992-09

8.  A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides.

Authors:  J Nissen-Meyer; H Holo; L S Håvarstein; K Sletten; I F Nes
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

9.  Cloning, expression, and nucleotide sequence of genes involved in production of pediocin PA-1, and bacteriocin from Pediococcus acidilactici PAC1.0.

Authors:  J D Marugg; C F Gonzalez; B S Kunka; A M Ledeboer; M J Pucci; M Y Toonen; S A Walker; L C Zoetmulder; P A Vandenbergh
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

10.  Characterization and purification of mesentericin Y105, an anti-Listeria bacteriocin from Leuconostoc mesenteroides.

Authors:  Y Héchard; B Dérijard; F Letellier; Y Cenatiempo
Journal:  J Gen Microbiol       Date:  1992-12
View more
  37 in total

1.  Engineering increased stability in the antimicrobial peptide pediocin PA-1.

Authors:  L Johnsen; G Fimland; V Eijsink; J Nissen-Meyer
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

2.  Rapid two-step procedure for large-scale purification of pediocin-like bacteriocins and other cationic antimicrobial peptides from complex culture medium.

Authors:  Marianne Uteng; Håvard Hildeng Hauge; Ilia Brondz; Jon Nissen-Meyer; Gunnar Fimland
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

3.  Isolation and Characterization of Pediocin NV 5 Producing Pediococcus acidilactici LAB 5 from Vacuum-Packed Fermented Meat Product.

Authors:  Vivekananda Mandal; Sukanta Kumar Sen; Narayan Chandra Mandal
Journal:  Indian J Microbiol       Date:  2011-01-26       Impact factor: 2.461

Review 4.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

5.  Determination of essential and variable residues in pediocin PA-1 by NNK scanning.

Authors:  Tatsuya Tominaga; Yoshinori Hatakeyama
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

6.  Insights into structure-activity relationships in the C-terminal region of divercin V41, a class IIa bacteriocin with high-level antilisterial activity.

Authors:  Jitka Rihakova; Vanessa W Petit; Katerina Demnerova; Hervé Prévost; Sylvie Rebuffat; Djamel Drider
Journal:  Appl Environ Microbiol       Date:  2009-01-30       Impact factor: 4.792

7.  Determination of comparative minimum inhibitory concentration (MIC) of bacteriocins produced by enterococci for selected isolates of multi-antibiotic resistant Enterococcus spp.

Authors:  Maryam Hassan; Yousef Javadzadeh; Farzaneh Lotfipour; Rajabali Badomchi
Journal:  Adv Pharm Bull       Date:  2011-12-15

Review 8.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

Review 9.  Bacteriocin production and different strategies for their recovery and purification.

Authors:  Anita Kumari Garsa; Rashmi Kumariya; S K Sood; Anil Kumar; Suman Kapila
Journal:  Probiotics Antimicrob Proteins       Date:  2014-03       Impact factor: 4.609

10.  Mutational analysis of mesentericin y105, an anti-Listeria bacteriocin, for determination of impact on bactericidal activity, in vitro secondary structure, and membrane interaction.

Authors:  Dany Morisset; Jean-Marc Berjeaud; Didier Marion; Christian Lacombe; Jacques Frère
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.